High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients - Concepedia

Concepedia

Publication | Open Access

High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients

DOI Full Paper Access

57

Citations

29

References

2008

Year

D. Rey, Bruno Hoën, P. Chavanet, Marie‐Paule Schmitt, Guillaume Hoizey, P. Meyer, Gilles Peytavin, Bruno Spire, Clotilde Allavena, Myriam Diemer,

Journal of Antimicrobial Chemotherapy

Abstract

In ARV-naive HIV-1-infected patients, the once-daily lamivudine, tenofovirDF and nevirapine regimen resulted in a high rate of early virological failures. The reasons for the failures remain unclear.

References

	Year	Citations

Page 1